BioCentury
ARTICLE | Company News

BioTime management update

September 13, 2010 7:00 AM UTC

BioTime Inc. (NYSE-A:BTIM), Alameda, Calif. Business: Hematology, Gene/Cell therapy Resigning: Steven Seinberg as CFO, effective Sept. 17, to return to practicing law at a private firm; SVP and COO Ro...